WuXi Biologics (Cayman) Inc (WXXWY)
3.85
-0.16
(-3.99%)
USD |
OTCM |
Nov 14, 12:27
WuXi Biologics Price: 3.85 for Nov. 14, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 13, 2024 | 3.97 | 4.10 | 3.97 | 4.01 | 19397.00 |
Nov 12, 2024 | 4.21 | 4.22 | 4.13 | 4.15 | 44328.00 |
Nov 11, 2024 | 4.248 | 4.27 | 4.21 | 4.21 | 25325.00 |
Nov 08, 2024 | 4.40 | 4.40 | 4.22 | 4.23 | 46336.00 |
Nov 07, 2024 | 4.50 | 4.58 | 4.49 | 4.53 | 40564.00 |
Nov 06, 2024 | 4.27 | 4.38 | 4.26 | 4.37 | 77352.00 |
Nov 05, 2024 | 4.38 | 4.42 | 4.38 | 4.40 | 31916.00 |
Nov 04, 2024 | 4.31 | 4.31 | 4.24 | 4.276 | 24933.00 |
Nov 01, 2024 | 4.23 | 4.23 | 4.14 | 4.145 | 18286.00 |
Oct 31, 2024 | 4.14 | 4.20 | 4.13 | 4.20 | 12831.00 |
Oct 30, 2024 | 4.19 | 4.20 | 4.17 | 4.18 | 40935.00 |
Oct 29, 2024 | 4.50 | 4.50 | 4.26 | 4.36 | 32417.00 |
Oct 28, 2024 | 4.45 | 4.52 | 4.43 | 4.48 | 50377.00 |
Oct 25, 2024 | 4.44 | 4.46 | 4.40 | 4.43 | 20914.00 |
Oct 24, 2024 | 4.41 | 4.41 | 4.14 | 4.165 | 15310.00 |
Oct 23, 2024 | 4.28 | 4.28 | 4.21 | 4.23 | 17909.00 |
Oct 22, 2024 | 4.07 | 4.25 | 4.07 | 4.22 | 35215.00 |
Oct 21, 2024 | 4.23 | 4.23 | 4.11 | 4.145 | 159068.0 |
Oct 18, 2024 | 4.18 | 4.59 | 4.15 | 4.23 | 93506.00 |
Oct 17, 2024 | 3.95 | 3.95 | 3.794 | 3.828 | 45066.00 |
Oct 16, 2024 | 3.94 | 4.03 | 3.93 | 3.98 | 49375.00 |
Oct 15, 2024 | 4.25 | 4.25 | 4.00 | 4.03 | 82885.00 |
Oct 14, 2024 | 4.51 | 4.51 | 4.34 | 4.399 | 58261.00 |
Oct 11, 2024 | 4.51 | 4.64 | 4.51 | 4.60 | 265796.0 |
Oct 10, 2024 | 4.59 | 4.65 | 4.543 | 4.605 | 33307.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.59
Minimum
Aug 22 2024
43.36
Maximum
Nov 20 2020
14.99
Average
12.82
Median
Jul 15 2020
Price Benchmarks
Zai Lab Ltd | 27.01 |
Sinovac Biotech Ltd | 6.47 |
CASI Pharmaceuticals Inc | 5.68 |
Adagene Inc | 2.35 |
LakeShore Biopharma Co Ltd | 2.90 |
Price Related Metrics
PE Ratio | 23.08 |
PS Ratio | 3.481 |
Price to Book Value | 1.414 |
Earnings Yield | 4.33% |
Market Cap | 7.909B |
Operating PE Ratio | 14.71 |
Normalized PE Ratio | 22.32 |